Avidity Biosciences
RNA
#1850
Rank
C$14.86 B
Marketcap
C$98.68
Share price
-0.08%
Change (1 day)
116.97%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: C$14.86 Billion

As of December 2025 Avidity Biosciences has a market cap of C$14.86 Billion. This makes Avidity Biosciences the world's 1850th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025C$14.86 B188.43%
2024C$5.15 B442.41%
2023C$0.95 B-52.51%
2022C$2.00 B40.87%
2021C$1.42 B16.34%
2020C$1.22 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of Avidity Biosciences was reported to be:

C$14.86 Billion
by Nasdaq info icon info icon
C$14.86 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
C$8.53 B-42.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.12 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.15 B-78.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.07 B-72.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.15 B-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$14.95 B 0.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$193.49 B 1,201.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$135.23 B 809.54%๐Ÿ‡ฌ๐Ÿ‡ง UK